Showing results (61-70 of 81) with videos related to
Sort By:
Pageof 9
Cardiovascular Diabetology|September 9, 2021
External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular diseaseLisanne C A Smidt, Frank L J Visseren, Wendela L de Ranitz-Greven, et al.BMC Endocrine Disorders|June 17, 2021
DPARD: rationale, design and initial results from the Dutch national diabetes registryJessica C G Bak, Dick Mul, Erik H Serné, et al.Diabetes Technology & Therapeutics|November 2, 2012
Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitusWendela L de Ranitz-Greven, Lotte Kaasenbrood, Wendy K Poucki, et al.The Lancet. Diabetes & Endocrinology|May 4, 2019
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trialEmanuele Bosi, Pratik Choudhary, Harold W de Valk, et al.Diabetes & Metabolic Syndrome|December 19, 2023
Potency of quality indicators in Dutch and international diabetes registriesJessica C G Bak, Erik H Serné, M W J M Wouters, et al.Chronobiology International|August 25, 2022
A randomized crossover trial assessing time of day snack consumption and resulting postprandial glycemic response in a real-life setting among healthy adultsRuth Timmer, Laurens Bogaardt, Walter J Brummelhuis, et al.Diabetologia|April 15, 2017
A core outcome set for studies evaluating the effectiveness of prepregnancy care for women with pregestational diabetesAoife M Egan, Sander Galjaard, Michael J A Maresh, et al.Diabetes, Obesity & Metabolism|July 29, 2024
Mortality patterns in Dutch diabetes outpatientsJessica C G Bak, Silvia A G de Vries, Erik H Serné, et al.BMJ Open|August 23, 2023
Dual hormone fully closed loop in type 1 diabetes: a randomised trial in the Netherlands - study protocolMilena Jancev, Frank J Snoek, Geert W J Frederix, et al.Diabetes, Obesity & Metabolism|September 22, 2023
Continuous glucose monitoring metrics and pregnancy outcomes in insulin-treated diabetes: A post-hoc analysis of the GlucoMOMS trialDoortje Rademaker, Anne W T van der Wel, Rik van Eekelen, et al.Pageof 9